Global Biosimilar Monoclonal Antibodies Market Research Report 2021 - Impact of COVID-19 on the Market

Publisher Name :
Date: 08-Mar-2022
No. of pages: 119

The Biosimilar Monoclonal Antibodies market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Biosimilar Monoclonal Antibodies market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Biosimilar Monoclonal Antibodies Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Biosimilar Monoclonal Antibodies market are:

Celltrion

Zydus

Boehringer Ingelheim

Amgen

Samsung

Shanghai CP Guojian Pharmaceutical

Dr Reddy's

Hospira

Sandoz

Most important types of Biosimilar Monoclonal Antibodies products covered in this report are:

Infliximab

Rituximab

Trastuzumab

Adalimumab

Other

Most widely used downstream fields of Biosimilar Monoclonal Antibodies market covered in this report are:

Oncology

Autoimmune Disease

Other

Major Regions or countries covered in this report:

North America

Europe

China

Japan

Middle East and Africa

South America

India

South Korea

Southeast Asia

Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2021-2026

Global Biosimilar Monoclonal Antibodies Market Research Report 2021 - Impact of COVID-19 on the Market

Table of Content

1 Biosimilar Monoclonal Antibodies Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Biosimilar Monoclonal Antibodies
1.3 Biosimilar Monoclonal Antibodies Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate from 2016-2026
1.4 Market Segmentation
1.4.1 Types of Biosimilar Monoclonal Antibodies
1.4.2 Applications of Biosimilar Monoclonal Antibodies
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Biosimilar Monoclonal Antibodies Industry Trends
1.5.2 Biosimilar Monoclonal Antibodies Drivers
1.5.3 Biosimilar Monoclonal Antibodies Market Challenges
1.5.4 Biosimilar Monoclonal Antibodies Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Biosimilar Monoclonal Antibodies Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Biosimilar Monoclonal Antibodies Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Biosimilar Monoclonal Antibodies Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Biosimilar Monoclonal Antibodies
2.2.1 Major Players Manufacturing Base of Biosimilar Monoclonal Antibodies in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Biosimilar Monoclonal Antibodies Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
2.3.3 Labor Cost of Biosimilar Monoclonal Antibodies
2.4 Market Channel Analysis of Biosimilar Monoclonal Antibodies
2.5 Major Down Stream Customers by Application

3 Global Biosimilar Monoclonal Antibodies Market, by Type
3.1 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)
3.2 Global Biosimilar Monoclonal Antibodies Production and Market Share by Type (2016-2021)
3.3 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate by Type (2016-2021)
3.3.1 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate of Infliximab
3.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate of Rituximab
3.3.3 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate of Trastuzumab
3.3.4 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate of Adalimumab
3.3.5 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate of Other
3.4 Global Biosimilar Monoclonal Antibodies Price Analysis by Type (2016-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Biosimilar Monoclonal Antibodies Market, by Application
4.1 Downstream Market Overview
4.2 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2016-2021)
4.3 Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate by Application (2016-2021)
4.3.1 Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Oncology (2016-2021)
4.3.2 Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Autoimmune Disease (2016-2021)
4.3.3 Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Other (2016-2021)

5 Global Biosimilar Monoclonal Antibodies Consumption, Revenue ($) by Region (2016-2021)
5.1 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2016-2021)
5.2 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Region (2016-2021)
5.3 Global Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4 North America Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4.1 North America Biosimilar Monoclonal Antibodies Market Under COVID-19
5.4.2 North America Biosimilar Monoclonal Antibodies SWOT Analysis
5.5 Europe Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.5.1 Europe Biosimilar Monoclonal Antibodies Market Under COVID-19
5.5.2 Europe Biosimilar Monoclonal Antibodies SWOT Analysis
5.6 China Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.6.1 China Biosimilar Monoclonal Antibodies Market Under COVID-19
5.6.2 China Biosimilar Monoclonal Antibodies SWOT Analysis
5.7 Japan Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.7.1 Japan Biosimilar Monoclonal Antibodies Market Under COVID-19
5.7.2 Japan Biosimilar Monoclonal Antibodies SWOT Analysis
5.8 Middle East and Africa Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.8.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Under COVID-19
5.8.2 Middle East and Africa Biosimilar Monoclonal Antibodies SWOT Analysis
5.9 India Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.9.1 India Biosimilar Monoclonal Antibodies Market Under COVID-19
5.9.2 India Biosimilar Monoclonal Antibodies SWOT Analysis
5.10 South America Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.10.1 South America Biosimilar Monoclonal Antibodies Market Under COVID-19
5.10.2 South America Biosimilar Monoclonal Antibodies SWOT Analysis
5.11 South Korea Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.11.1 South Korea Biosimilar Monoclonal Antibodies Market Under COVID-19
5.11.2 South Korea Biosimilar Monoclonal Antibodies SWOT Analysis
5.12 Southeast Asia Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
5.12.1 Southeast Asia Biosimilar Monoclonal Antibodies Market Under COVID-19
5.12.2 Southeast Asia Biosimilar Monoclonal Antibodies SWOT Analysis

6 Global Biosimilar Monoclonal Antibodies Production by Top Regions (2016-2021)
6.1 Global Biosimilar Monoclonal Antibodies Production by Top Regions (2016-2021)
6.2 North America Biosimilar Monoclonal Antibodies Production and Growth Rate
6.3 Europe Biosimilar Monoclonal Antibodies Production and Growth Rate
6.4 China Biosimilar Monoclonal Antibodies Production and Growth Rate
6.5 Japan Biosimilar Monoclonal Antibodies Production and Growth Rate
6.6 India Biosimilar Monoclonal Antibodies Production and Growth Rate

7 Global Biosimilar Monoclonal Antibodies Consumption by Regions (2016-2021)
7.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions (2016-2021)
7.2 North America Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.3 Europe Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.4 China Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.5 Japan Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.6 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.7 India Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.8 South America Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.9 South Korea Biosimilar Monoclonal Antibodies Consumption and Growth Rate
7.10 Southeast Asia Biosimilar Monoclonal Antibodies Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Celltrion Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.2.3 Celltrion Sales, Revenue, Price, Gross Margin 2016-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Zydus Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.3.3 Zydus Sales, Revenue, Price, Gross Margin 2016-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Boehringer Ingelheim Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.4.3 Boehringer Ingelheim Sales, Revenue, Price, Gross Margin 2016-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Amgen Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.5.3 Amgen Sales, Revenue, Price, Gross Margin 2016-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Samsung Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.6.3 Samsung Sales, Revenue, Price, Gross Margin 2016-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Shanghai CP Guojian Pharmaceutical Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.7.3 Shanghai CP Guojian Pharmaceutical Sales, Revenue, Price, Gross Margin 2016-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Dr Reddy's Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.8.3 Dr Reddy's Sales, Revenue, Price, Gross Margin 2016-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Hospira Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.9.3 Hospira Sales, Revenue, Price, Gross Margin 2016-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Sandoz Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Biosimilar Monoclonal Antibodies Product Profiles, Application and Specification
8.10.3 Sandoz Sales, Revenue, Price, Gross Margin 2016-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Biosimilar Monoclonal Antibodies Market Analysis and Forecast by Type and Application
9.1 Global Biosimilar Monoclonal Antibodies Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Infliximab Market Revenue and Volume Forecast (2021-2026)
9.1.2 Rituximab Market Revenue and Volume Forecast (2021-2026)
9.1.3 Trastuzumab Market Revenue and Volume Forecast (2021-2026)
9.1.4 Adalimumab Market Revenue and Volume Forecast (2021-2026)
9.1.5 Other Market Revenue and Volume Forecast (2021-2026)
9.2 Global Biosimilar Monoclonal Antibodies Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Oncology Market Revenue and Volume Forecast (2021-2026)
9.2.2 Autoimmune Disease Market Revenue and Volume Forecast (2021-2026)
9.2.3 Other Market Revenue and Volume Forecast (2021-2026)

10 Biosimilar Monoclonal Antibodies Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Biosimilar Monoclonal Antibodies Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
List of Tables and Figures
Figure Product Picture of Biosimilar Monoclonal Antibodies
Table Product Specification of Biosimilar Monoclonal Antibodies
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilar Monoclonal Antibodies
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate from 2016-2026
Table Different Types of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type (2020-2026)
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) Segment by Type from 2016-2021
Figure Global Biosimilar Monoclonal Antibodies Market Share by Types in 2020
Figure Biosimilar Monoclonal Antibodies Infliximab Picture
Figure Biosimilar Monoclonal Antibodies Rituximab Picture
Figure Biosimilar Monoclonal Antibodies Trastuzumab Picture
Figure Biosimilar Monoclonal Antibodies Adalimumab Picture
Figure Biosimilar Monoclonal Antibodies Other Picture
Table Different Applications of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Applications (2020-2026)
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) Segment by Applications from 2016-2021
Figure Global Biosimilar Monoclonal Antibodies Market Share by Applications in 2020
Figure Oncology Picture
Figure Autoimmune Disease Picture
Figure Other Picture
Table Research Regions of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Region (2020-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Share by Regions in 2020
Figure North America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure China Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure India Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure South America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure South Korea Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2016-2021)
Table SWOT Analysis
Table Market Challenges
Table Market Restraints
Table Industry News
Table Industry Policies
Table Mergers & Acquisitions, Expansion Plans
Table Influence of COVID-19 Outbreak on Biosimilar Monoclonal Antibodies Industry Development
Figure Industry Chain Analysis of Biosimilar Monoclonal Antibodies
Table Major Players Manufacturing Base of Biosimilar Monoclonal Antibodies in 2020
Table Major Players Market Distribution in 2020
Figure Production Process of Biosimilar Monoclonal Antibodies
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure Channel Status of Biosimilar Monoclonal Antibodies
Table Major Distributors of Biosimilar Monoclonal Antibodies with Contact Information
Table Global Biosimilar Monoclonal Antibodies Revenue ($) by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Production by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Production Share by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Production Share by Type (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate of Infliximab
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate of Rituximab
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate of Trastuzumab
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate of Adalimumab
Figure Global Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate of Other
Figure Global Biosimilar Monoclonal Antibodies Price by Type (2016-2021)
Figure Downstream Market Overview
Table Global Biosimilar Monoclonal Antibodies Consumption by Application (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Oncology (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Autoimmune Disease (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption and Growth Rate of Other (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue ($) by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Region (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table North America Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table North America Biosimilar Monoclonal Antibodies SWOT Analysis
Table Europe Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies SWOT Analysis
Table China Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table China Biosimilar Monoclonal Antibodies SWOT Analysis
Table Japan Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Japan Biosimilar Monoclonal Antibodies SWOT Analysis
Table Middle East and Africa Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Middle East and Africa Biosimilar Monoclonal Antibodies SWOT Analysis
Table India Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table India Biosimilar Monoclonal Antibodies SWOT Analysis
Table South America Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table South America Biosimilar Monoclonal Antibodies SWOT Analysis
Table South Korea Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table South Korea Biosimilar Monoclonal Antibodies SWOT Analysis
Table Southeast Asia Biosimilar Monoclonal Antibodies Consumption, Revenue, Price and Gross Margin (2016-2021)
Table Southeast Asia Biosimilar Monoclonal Antibodies SWOT Analysis
Table Global Biosimilar Monoclonal Antibodies Production by Top Regions (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Production Share by Top Regions (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Production and Growth Rate Analysis (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Production and Growth Rate Analysis (2016-2021)
Figure China Biosimilar Monoclonal Antibodies Production and Growth Rate Analysis (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Production and Growth Rate Analysis (2016-2021)
Figure India Biosimilar Monoclonal Antibodies Production and Growth Rate Analysis (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption by Regions (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption Share by Regions (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure China Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure India Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure South America Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure South Korea Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Consumption and Growth Rate Analysis (2016-2021)
Figure Top 3 Market Share of Biosimilar Monoclonal Antibodies Companies in 2020
Figure Top 6 Market Share of Biosimilar Monoclonal Antibodies Companies in 2020
Table Major Players Revenue ($) Share (2016-2021)
Table Company Profiles
Table Product Profiles, Application and Specification
Table Celltrion Company Profiles
Table Celltrion Sales, Revenue, Price, Gross Margin 2016-2021
Figure Celltrion Sales and Growth Rate
Figure Celltrion Revenue ($) Market Share 2016-2021
Table Zydus Company Profiles
Table Zydus Sales, Revenue, Price, Gross Margin 2016-2021
Figure Zydus Sales and Growth Rate
Figure Zydus Revenue ($) Market Share 2016-2021
Table Boehringer Ingelheim Company Profiles
Table Boehringer Ingelheim Sales, Revenue, Price, Gross Margin 2016-2021
Figure Boehringer Ingelheim Sales and Growth Rate
Figure Boehringer Ingelheim Revenue ($) Market Share 2016-2021
Table Amgen Company Profiles
Table Amgen Sales, Revenue, Price, Gross Margin 2016-2021
Figure Amgen Sales and Growth Rate
Figure Amgen Revenue ($) Market Share 2016-2021
Table Samsung Company Profiles
Table Samsung Sales, Revenue, Price, Gross Margin 2016-2021
Figure Samsung Sales and Growth Rate
Figure Samsung Revenue ($) Market Share 2016-2021
Table Shanghai CP Guojian Pharmaceutical Company Profiles
Table Shanghai CP Guojian Pharmaceutical Sales, Revenue, Price, Gross Margin 2016-2021
Figure Shanghai CP Guojian Pharmaceutical Sales and Growth Rate
Figure Shanghai CP Guojian Pharmaceutical Revenue ($) Market Share 2016-2021
Table Dr Reddy's Company Profiles
Table Dr Reddy's Sales, Revenue, Price, Gross Margin 2016-2021
Figure Dr Reddy's Sales and Growth Rate
Figure Dr Reddy's Revenue ($) Market Share 2016-2021
Table Hospira Company Profiles
Table Hospira Sales, Revenue, Price, Gross Margin 2016-2021
Figure Hospira Sales and Growth Rate
Figure Hospira Revenue ($) Market Share 2016-2021
Table Sandoz Company Profiles
Table Sandoz Sales, Revenue, Price, Gross Margin 2016-2021
Figure Sandoz Sales and Growth Rate
Figure Sandoz Revenue ($) Market Share 2016-2021
Table Global Biosimilar Monoclonal Antibodies Market Revenue ($) Forecast, by Type
Table Global Biosimilar Monoclonal Antibodies Market Volume Forecast, by Type
Figure Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate Forecast of Infliximab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Volume and Growth Rate Forecast of Infliximab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate Forecast of Rituximab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Volume and Growth Rate Forecast of Rituximab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate Forecast of Trastuzumab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Volume and Growth Rate Forecast of Trastuzumab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate Forecast of Adalimumab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Volume and Growth Rate Forecast of Adalimumab (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate Forecast of Other (2021-2026)
Figure Global Biosimilar Monoclonal Antibodies Market Volume and Growth Rate Forecast of Other (2021-2026)
Table Global Market Revenue ($) Forecast by Application (2021-2026)
Table Global Market Volume Forecast by Application (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Oncology (2021-2026)
Figure Market Volume and Growth Rate Forecast of Oncology (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Autoimmune Disease (2021-2026)
Figure Market Volume and Growth Rate Forecast of Autoimmune Disease (2021-2026)
Figure Market Revenue ($) and Growth Rate Forecast of Other (2021-2026)
Figure Market Volume and Growth Rate Forecast of Other (2021-2026)
Figure North America Market Supply and Growth Rate Forecast (2021-2026)
Figure North America Demand and Growth Rate Forecast (2021-2026)
Figure Europe Market Supply and Growth Rate Forecast (2021-2026)
Figure Europe Demand and Growth Rate Forecast (2021-2026)
Figure China Market Supply and Growth Rate Forecast (2021-2026)
Figure China Demand and Growth Rate Forecast (2021-2026)
Figure Japan Market Supply and Growth Rate Forecast (2021-2026)
Figure Japan Demand and Growth Rate Forecast (2021-2026)
Figure Middle East and Africa Market Supply and Growth Rate Forecast (2021-2026)
Figure Middle East and Africa Demand and Growth Rate Forecast (2021-2026)
Figure India Market Supply and Growth Rate Forecast (2021-2026)
Figure India Demand and Growth Rate Forecast (2021-2026)
Figure South America Market Supply and Growth Rate Forecast (2021-2026)
Figure South America Demand and Growth Rate Forecast (2021-2026)
Figure South Korea Market Supply and Growth Rate Forecast (2021-2026)
Figure South Korea Demand and Growth Rate Forecast (2021-2026)
Figure Southeast Asia Market Supply and Growth Rate Forecast (2021-2026)
Figure Southeast Asia Demand and Growth Rate Forecast (2021-2026)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs